127 related articles for article (PubMed ID: 8093658)
1. [Antimicrotubule agents].
Niitani H; Hisakatsu S
Gan To Kagaku Ryoho; 1993 Jan; 20(1):34-41. PubMed ID: 8093658
[TBL] [Abstract][Full Text] [Related]
2. [Recent results of anticancer drugs acting on microtubules--navelbine, taxol and taxotere for the treatment of lung cancer].
Kawahara M; Furuse K
Gan To Kagaku Ryoho; 1992 Nov; 19(13):2150-6. PubMed ID: 1359840
[No Abstract] [Full Text] [Related]
3. Taxol: a novel investigational antimicrotubule agent.
Rowinsky EK; Cazenave LA; Donehower RC
J Natl Cancer Inst; 1990 Aug; 82(15):1247-59. PubMed ID: 1973737
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of action of E7010, an orally active sulfonamide antitumor agent: inhibition of mitosis by binding to the colchicine site of tubulin.
Yoshimatsu K; Yamaguchi A; Yoshino H; Koyanagi N; Kitoh K
Cancer Res; 1997 Aug; 57(15):3208-13. PubMed ID: 9242451
[TBL] [Abstract][Full Text] [Related]
5. [Microtubules and antineoplastic drugs].
Arioka H; Saijo N
Gan To Kagaku Ryoho; 1994 Apr; 21(5):583-90. PubMed ID: 7908790
[TBL] [Abstract][Full Text] [Related]
6. New directions for chemotherapy in non-small-cell lung cancer.
Green MR
Chest; 1993 Apr; 103(4 Suppl):370S-372S. PubMed ID: 8096453
[TBL] [Abstract][Full Text] [Related]
7. [Taxoids: structural and experimental properties].
Lavelle F; Combeau C; Commerçon A
Bull Cancer; 1995 Apr; 82(4):249-64. PubMed ID: 10846536
[TBL] [Abstract][Full Text] [Related]
8. New drugs in non-small cell lung cancer. An overview.
Giaccone G
Lung Cancer; 1995 Apr; 12 Suppl 1():S155-62. PubMed ID: 7551924
[TBL] [Abstract][Full Text] [Related]
9. [Anticancer substances of vegetable origin. Spindle poisons: vincaleukoblastine, leurocristine and navelbine; taxol and taxotere].
Guéritte-Voegelein F; Guénard D; Potier P
C R Seances Soc Biol Fil; 1992; 186(5):433-40. PubMed ID: 1363958
[TBL] [Abstract][Full Text] [Related]
10. [Antimitotic agents].
Fukuoka K; Saijo N
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1519-25. PubMed ID: 9309150
[TBL] [Abstract][Full Text] [Related]
11. Advances in vinca-alkaloids: Navelbine.
Marty M; Extra JM; Espie M; Leandri S; Besenval M; Krikorian A
Nouv Rev Fr Hematol (1978); 1989; 31(2):77-84. PubMed ID: 2671933
[TBL] [Abstract][Full Text] [Related]
12. Immunofluorescence study of the action of navelbine, vincristine and vinblastine on mitotic and axonal microtubules.
Binet S; Chaineau E; Fellous A; Lataste H; Krikorian A; Couzinier JP; Meininger V
Int J Cancer; 1990 Aug; 46(2):262-6. PubMed ID: 2200754
[TBL] [Abstract][Full Text] [Related]
13. DNA damage increases sensitivity to vinca alkaloids and decreases sensitivity to taxanes through p53-dependent repression of microtubule-associated protein 4.
Zhang CC; Yang JM; Bash-Babula J; White E; Murphy M; Levine AJ; Hait WN
Cancer Res; 1999 Aug; 59(15):3663-70. PubMed ID: 10446979
[TBL] [Abstract][Full Text] [Related]
14. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors.
Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K
Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285
[TBL] [Abstract][Full Text] [Related]
15. 'Rings' of F-actin form around the nucleus in cultured human MCF7 adenocarcinoma cells upon exposure to both taxol and taxotere.
Rosenblum MD; Shivers RR
Comp Biochem Physiol C Toxicol Pharmacol; 2000 Jan; 125(1):121-31. PubMed ID: 11790336
[TBL] [Abstract][Full Text] [Related]
16. [Characterization of the mechanism of cross-resistance to vinca alkaloids and taxoids in the human J82 bladder tumor cell line].
Debal V; Allam N; Morjani H; Millot JM; Gourdier B; Breillout F; Manfait M
Bull Cancer; 1994 Oct; 81(10):891-3. PubMed ID: 7734773
[TBL] [Abstract][Full Text] [Related]
17. Cryptophycin: a new antimicrotubule agent active against drug-resistant cells.
Smith CD; Zhang X; Mooberry SL; Patterson GM; Moore RE
Cancer Res; 1994 Jul; 54(14):3779-84. PubMed ID: 7913408
[TBL] [Abstract][Full Text] [Related]
18. The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents.
Rowinsky EK
Annu Rev Med; 1997; 48():353-74. PubMed ID: 9046968
[TBL] [Abstract][Full Text] [Related]
19. Novel taxane formulations and microtubule-binding agents in non-small-cell lung cancer.
Edelman MJ
Clin Lung Cancer; 2009 Mar; 10 Suppl 1():S30-4. PubMed ID: 19362944
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the cytotoxic mechanism mediated by baccatin III, the synthetic precursor of taxol.
Pengsuparp T; Kingston DG; Neidigh KA; Cordell GA; Pezzuto JM
Chem Biol Interact; 1996 Aug; 101(2):103-14. PubMed ID: 8760392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
